TBRG
TBRG
TruBridge, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $86.11M ▲ | $39.99M ▼ | $5.6M ▲ | 6.51% ▲ | $0.37 ▲ | $14.54M ▲ |
| Q2-2025 | $85.73M ▼ | $40.83M ▲ | $2.58M ▲ | 3.01% ▲ | $0.17 ▲ | $10.37M ▼ |
| Q1-2025 | $87.21M ▼ | $39.53M ▼ | $459K ▲ | 0.53% ▲ | $0.03 ▲ | $14.72M ▲ |
| Q4-2024 | $90.84M ▲ | $40.61M ▲ | $-3.06M ▲ | -3.37% ▲ | $-0.39 ▼ | $14.1M ▲ |
| Q3-2024 | $83.83M | $39.52M | $-9.81M | -11.7% | $0.45 | $8.03M |
What's going well?
Net income and earnings per share more than doubled, showing the company can turn steady sales into stronger profits. Operating expenses are under better control, and efficiency is improving.
What's concerning?
Gross margins are slipping, and interest expense is now a major drag on profits. The big jump in net income was helped by a tax benefit, which may not repeat.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $19.92K ▼ | $399.41M ▲ | $219.05M ▲ | $180.36M ▲ |
| Q2-2025 | $12.28M ▲ | $390.15M ▲ | $216.98M ▼ | $173.17M ▲ |
| Q1-2025 | $10.12M ▼ | $388.84M ▼ | $220.33M ▼ | $168.51M ▼ |
| Q4-2024 | $12.32M ▲ | $394.43M ▼ | $225.74M ▼ | $168.69M ▼ |
| Q3-2024 | $8.59M | $401.53M | $228.89M | $172.65M |
What's financially strong about this company?
The company has positive equity, improved book value, and is managing inventory well. Most debt is long-term, so there are no immediate repayment pressures.
What are the financial risks or weaknesses?
Cash reserves have collapsed, leaving the company exposed to any revenue shortfall. High debt and negative retained earnings show a risky financial position, and a big drop in intangible assets could mean recent losses or write-downs.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.6M ▲ | $13.59M ▲ | $-3.99M ▲ | $-1.96M ▼ | $7.64M ▲ | $13.65M ▲ |
| Q2-2025 | $2.58M ▲ | $8.76M ▲ | $-4.73M ▼ | $-1.88M ▲ | $2.15M ▲ | $8.21M ▲ |
| Q1-2025 | $459K ▲ | $5.76M ▼ | $-2.23M ▼ | $-5.73M ▼ | $-2.2M ▼ | $1.43M ▼ |
| Q4-2024 | $-3.06M ▲ | $10.3M ▲ | $-1.68M ▲ | $-4.88M ▼ | $3.74M ▲ | $6.14M ▲ |
| Q3-2024 | $-11.13M | $10.11M | $-5.31M | $-3.92M | $877K | $4.8M |
What's strong about this company's cash flow?
Cash from operations is growing fast, now at $13.6 million. Free cash flow is strong and rising, and the company is paying down debt while building up cash. No reliance on outside funding.
What are the cash flow concerns?
Working capital used up some cash this quarter, and shareholder returns are minimal. Stock-based compensation, while down, still dilutes shareholders a bit.
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at TruBridge, Inc.'s financial evolution and strategic trajectory over the past five years.
TruBridge combines steady revenue growth, strong and stable gross margins, and a focused niche in rural and community healthcare with a meaningful innovation agenda built around AI and analytics. Its integrated EHR and revenue cycle offerings, risk‑sharing nTrust model, and HFMA‑validated services give it credibility and stickiness with financially constrained hospitals. The business has shown it can generate solid operating cash flow in most years, and recent actions to reduce debt and improve cash generation suggest management is attentive to balance-sheet health.
The main concerns are deteriorated profitability, increased leverage, and volatile free cash flow. Operating and interest expenses have outpaced revenue growth, leading to losses and negative retained earnings, and leaving less room for error. Higher debt levels amplify the impact of earnings swings, while liquidity metrics, although still acceptable, are trending downward. Competitive and structural risks in the rural healthcare market, plus the need to execute complex initiatives like offshore expansion and deep AI integration, add further uncertainty.
The outlook appears mixed but improving. On one hand, the company’s niche focus, product portfolio, and AI‑driven innovation strategy position it to benefit as healthcare providers seek efficiency and automation. On the other hand, it must convert those advantages into durable profitability, stabilize cash flows, and continue to de‑risk the balance sheet. Recent improvements in EBITDA, operating income, free cash flow, and debt reduction point toward a potential turnaround, but the track record of volatility means that a sustained recovery is not yet assured and will require multiple periods of consistent execution to validate.
About TruBridge, Inc.
https://www.trubridge.comTruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $86.11M ▲ | $39.99M ▼ | $5.6M ▲ | 6.51% ▲ | $0.37 ▲ | $14.54M ▲ |
| Q2-2025 | $85.73M ▼ | $40.83M ▲ | $2.58M ▲ | 3.01% ▲ | $0.17 ▲ | $10.37M ▼ |
| Q1-2025 | $87.21M ▼ | $39.53M ▼ | $459K ▲ | 0.53% ▲ | $0.03 ▲ | $14.72M ▲ |
| Q4-2024 | $90.84M ▲ | $40.61M ▲ | $-3.06M ▲ | -3.37% ▲ | $-0.39 ▼ | $14.1M ▲ |
| Q3-2024 | $83.83M | $39.52M | $-9.81M | -11.7% | $0.45 | $8.03M |
What's going well?
Net income and earnings per share more than doubled, showing the company can turn steady sales into stronger profits. Operating expenses are under better control, and efficiency is improving.
What's concerning?
Gross margins are slipping, and interest expense is now a major drag on profits. The big jump in net income was helped by a tax benefit, which may not repeat.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $19.92K ▼ | $399.41M ▲ | $219.05M ▲ | $180.36M ▲ |
| Q2-2025 | $12.28M ▲ | $390.15M ▲ | $216.98M ▼ | $173.17M ▲ |
| Q1-2025 | $10.12M ▼ | $388.84M ▼ | $220.33M ▼ | $168.51M ▼ |
| Q4-2024 | $12.32M ▲ | $394.43M ▼ | $225.74M ▼ | $168.69M ▼ |
| Q3-2024 | $8.59M | $401.53M | $228.89M | $172.65M |
What's financially strong about this company?
The company has positive equity, improved book value, and is managing inventory well. Most debt is long-term, so there are no immediate repayment pressures.
What are the financial risks or weaknesses?
Cash reserves have collapsed, leaving the company exposed to any revenue shortfall. High debt and negative retained earnings show a risky financial position, and a big drop in intangible assets could mean recent losses or write-downs.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.6M ▲ | $13.59M ▲ | $-3.99M ▲ | $-1.96M ▼ | $7.64M ▲ | $13.65M ▲ |
| Q2-2025 | $2.58M ▲ | $8.76M ▲ | $-4.73M ▼ | $-1.88M ▲ | $2.15M ▲ | $8.21M ▲ |
| Q1-2025 | $459K ▲ | $5.76M ▼ | $-2.23M ▼ | $-5.73M ▼ | $-2.2M ▼ | $1.43M ▼ |
| Q4-2024 | $-3.06M ▲ | $10.3M ▲ | $-1.68M ▲ | $-4.88M ▼ | $3.74M ▲ | $6.14M ▲ |
| Q3-2024 | $-11.13M | $10.11M | $-5.31M | $-3.92M | $877K | $4.8M |
What's strong about this company's cash flow?
Cash from operations is growing fast, now at $13.6 million. Free cash flow is strong and rising, and the company is paying down debt while building up cash. No reliance on outside funding.
What are the cash flow concerns?
Working capital used up some cash this quarter, and shareholder returns are minimal. Stock-based compensation, while down, still dilutes shareholders a bit.
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at TruBridge, Inc.'s financial evolution and strategic trajectory over the past five years.
TruBridge combines steady revenue growth, strong and stable gross margins, and a focused niche in rural and community healthcare with a meaningful innovation agenda built around AI and analytics. Its integrated EHR and revenue cycle offerings, risk‑sharing nTrust model, and HFMA‑validated services give it credibility and stickiness with financially constrained hospitals. The business has shown it can generate solid operating cash flow in most years, and recent actions to reduce debt and improve cash generation suggest management is attentive to balance-sheet health.
The main concerns are deteriorated profitability, increased leverage, and volatile free cash flow. Operating and interest expenses have outpaced revenue growth, leading to losses and negative retained earnings, and leaving less room for error. Higher debt levels amplify the impact of earnings swings, while liquidity metrics, although still acceptable, are trending downward. Competitive and structural risks in the rural healthcare market, plus the need to execute complex initiatives like offshore expansion and deep AI integration, add further uncertainty.
The outlook appears mixed but improving. On one hand, the company’s niche focus, product portfolio, and AI‑driven innovation strategy position it to benefit as healthcare providers seek efficiency and automation. On the other hand, it must convert those advantages into durable profitability, stabilize cash flows, and continue to de‑risk the balance sheet. Recent improvements in EBITDA, operating income, free cash flow, and debt reduction point toward a potential turnaround, but the track record of volatility means that a sustained recovery is not yet assured and will require multiple periods of consistent execution to validate.

CEO
Christopher L. Fowler
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
VTS.AX
Weight:0.00%
Shares:446.27K
IWM
Weight:0.01%
Shares:239.90K
XSU.TO
Weight:0.01%
Shares:239.90K
Summary
Showing Top 3 of 59
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
NELLORE CAPITAL MANAGEMENT LLC
Shares:915.03K
Value:$17.65M
BLACKROCK, INC.
Shares:777.76K
Value:$15M
VANGUARD GROUP INC
Shares:755.37K
Value:$14.57M
Summary
Showing Top 3 of 100

